An eyecatching rebrand to reposition Colonis as a standalone entity
Despite its global achievements in value-added medicines (VAMs), Colonis had long been concealed within its parent company. The lack of brand recognition posed significant obstacles to its growth and market presence. The challenge was clear: to reposition Colonis as a leading player in VAMs, boost its visibility and differentiate it effectively from competitors.